Technical Analysis for ABIO - ARCA biopharma, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Bearish Engulfing | Bearish | -2.10% | |
Fell Below 20 DMA | Bearish | -2.10% | |
MACD Bearish Signal Line Cross | Bearish | -2.10% | |
Slingshot Bullish | Bullish Swing Setup | -2.10% | |
Wide Range Bar | Range Expansion | -2.10% | |
New 52 Week High | Strength | -2.10% | |
Outside Day | Range Expansion | -2.10% | |
Gapped Up | Strength | -2.10% |
Alert | Time |
---|---|
Down 3% | about 4 hours ago |
Down 2 % | about 4 hours ago |
Down 1% | about 4 hours ago |
Rose Above Previous Day's High | 3 days ago |
New 52 Week High | 3 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 04/22/2024
ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction. ARCA biopharma, Inc. is headquartered in Broomfield, Colorado.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cardiovascular Disease Heart Failure Vascular Disease Dysfunction Heart Disease Cardiac Arrhythmia Atrial Fibrillation Ventricular Dysfunction
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cardiovascular Disease Heart Failure Vascular Disease Dysfunction Heart Disease Cardiac Arrhythmia Atrial Fibrillation Ventricular Dysfunction
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.49 |
52 Week Low | 1.56 |
Average Volume | 1,818,893 |
200-Day Moving Average | 2.09 |
50-Day Moving Average | 2.83 |
20-Day Moving Average | 3.44 |
10-Day Moving Average | 3.45 |
Average True Range | 0.32 |
RSI (14) | 49.75 |
ADX | 42.47 |
+DI | 24.52 |
-DI | 22.25 |
Chandelier Exit (Long, 3 ATRs) | 3.54 |
Chandelier Exit (Short, 3 ATRs) | 4.04 |
Upper Bollinger Bands | 3.82 |
Lower Bollinger Band | 3.05 |
Percent B (%b) | 0.27 |
BandWidth | 22.38 |
MACD Line | 0.15 |
MACD Signal Line | 0.20 |
MACD Histogram | -0.0417 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.47 | ||||
Resistance 3 (R3) | 3.47 | 3.39 | 3.44 | ||
Resistance 2 (R2) | 3.39 | 3.34 | 3.40 | 3.42 | |
Resistance 1 (R1) | 3.33 | 3.31 | 3.36 | 3.33 | 3.41 |
Pivot Point | 3.25 | 3.25 | 3.27 | 3.26 | 3.25 |
Support 1 (S1) | 3.19 | 3.20 | 3.22 | 3.19 | 3.11 |
Support 2 (S2) | 3.11 | 3.17 | 3.12 | 3.10 | |
Support 3 (S3) | 3.05 | 3.11 | 3.09 | ||
Support 4 (S4) | 3.05 |